{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:16:00Z","timestamp":1790007360219,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Wujin District Project Foundation","award":["WS202102"],"award-info":[{"award-number":["WS202102"]}]},{"name":"Young Talent Development Plan of Changzhou Health Commission","award":["CZQM2021026"],"award-info":[{"award-number":["CZQM2021026"]}]},{"name":"Science and Technology Development Foundation of the affliate hospitals of Xuzhou Medical university","award":["XYFY2021023"],"award-info":[{"award-number":["XYFY2021023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Thermal ablation, including microwave ablation (MWA) and radiofrequency ablation (RFA), has been recommended for the treatment of primary hyperparathyroidism (PHPT) and refractory secondary hyperparathyroidism (SHPT). This meta-analysis was conducted to evaluate the efficacy and safety of MWA and RFA in patients with PHPT and refractory SHPT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Databases including PubMed, EMbase, the Cochrane Library, CNKI (China National Knowledge Infrastructure), and Wanfang were searched from inception to\u00a0December 5, 2022. Eligible studies comparing MWA and RFA for PHPT and refractory SHPT were included. Data were analyzed using Review Manager software, version 5.3.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Five studies were included in the meta-analysis. Two were retrospective cohort studies, and three were RCTs. Overall, 294 patients were included in the MWA group, and 194 patients were included in the RFA group. Compared with RFA for refractory SHPT, MWA had a shorter operation time for a single lesion (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01) and a higher complete ablation rate for a single lesion\u2009\u2265\u200915\u00a0mm (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01) but did not show a difference in the complete ablation rate for a single lesion\u2009&lt;\u200915\u00a0mm (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05). There were no significant differences between MWA and RFA for refractory SHPT concerning parathyroid hormone (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05), calcium (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05), and phosphorus levels (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05) within 12\u00a0months after ablation, except that calcium (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01) and phosphorus levels (<jats:italic>P<\/jats:italic>\u2009=\u20090.02) in the RFA group were lower than those in the MWA group at one month after ablation. There was no significant difference between MWA and RFA concerning the cure rate of PHPT (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05). There were no significant differences between MWA and RFA for PHPT and refractory SHPT concerning the complications of hoarseness (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05) and hypocalcaemia (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>MWA had a shorter operation time for single lesions and a higher complete ablation rate for large lesions in patients with refractory SHPT. However, there was no significant difference in efficacy and safety between MWA and RFA in cases of both PHPT and refractory SHPT. Both MWA and RFA are effective treatment methods for PHPT and refractory SHPT.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11255-023-03543-y","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T08:03:25Z","timestamp":1678349005000},"page":"2237-2247","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Microwave ablation versus radiofrequency ablation for patients with primary and secondary hyperparathyroidism: a meta-analysis"],"prefix":"10.1007","volume":"55","author":[{"given":"Wei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifeng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weigang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingkui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yani","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,9]]},"reference":[{"issue":"10116","key":"3543_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","volume":"391","author":"JP Bilezikian","year":"2018","unstructured":"Bilezikian JP, Bandeira L, Khan A et al (2018) Hyperparathyroidism. Lancet 391(10116):168\u2013178","journal-title":"Lancet"},{"issue":"9684","key":"3543_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","volume":"374","author":"WD Fraser","year":"2009","unstructured":"Fraser WD (2009) Hyperparathyroidism. Lancet 374(9684):145\u2013158","journal-title":"Lancet"},{"key":"3543_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12955-015-0266-9","volume":"13","author":"EW Davies","year":"2015","unstructured":"Davies EW, Matza LS, Worth G et al (2015) Health state utilities associated with major clinical events in the context of secondary hyperparathyroidism and chronic kidney disease requiring dialysis. Health Qual Life Outcomes 13:90","journal-title":"Health Qual Life Outcomes"},{"issue":"Pt 5","key":"3543_CR4","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1258\/acb.2012.012004","volume":"49","author":"R Lewis","year":"2012","unstructured":"Lewis R (2012) Mineral and bone disorders in chronic kidney disease: new insights into mechanism and management. Ann Clin Biochem 49(Pt 5):432\u2013440","journal-title":"Ann Clin Biochem"},{"key":"3543_CR5","unstructured":"Kidney Disease: improving global outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl  (113):S1\u2013S130"},{"issue":"2","key":"3543_CR6","first-page":"303","volume":"10","author":"NG de la Torre","year":"2003","unstructured":"de la Torre NG, Wass JA, Turner HE (2003) Parathyroid adenomas and cardiovascular risk. Endocr Relat Cancer 10(2):303\u2013322","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"3543_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/nrneph.2012.248","volume":"9","author":"ME Grams","year":"2013","unstructured":"Grams ME, Coresh J (2013) Assessing risk in chronic kidney disease: a methodological review. Nat Rev Nephrol 9(1):18\u201325","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"3543_CR8","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","volume":"151","author":"SM Wilhelm","year":"2016","unstructured":"Wilhelm SM, Wang TS, Ruan DT et al (2016) The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg 151(10):959\u2013968","journal-title":"JAMA Surg"},{"issue":"1","key":"3543_CR9","first-page":"835","volume":"36","author":"F Liu","year":"2019","unstructured":"Liu F, Yu X, Liu Z et al (2019) Comparison of ultrasound-guided percutaneous microwave ablation and parathyroidectomy for primary hyperparathyroidism. Int J Hyperthermia 36(1):835\u2013840","journal-title":"Int J Hyperthermia"},{"key":"3543_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ijsu.2019.08.004","volume":"70","author":"L Gong","year":"2019","unstructured":"Gong L, Tang W, Lu J, Xu W (2019) Thermal ablation versus parathyroidectomy for secondary hyperparathyroidism: a meta-analysis. Int J Surg 70:13\u201318","journal-title":"Int J Surg"},{"issue":"10","key":"3543_CR11","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1210\/jc.2014-1417","volume":"99","author":"C Marcocci","year":"2014","unstructured":"Marcocci C, Bollerslev J, Khan AA, Shoback DM (2014) Medical management of primary hyperparathyroidism: proceedings of the fourth international workshop on the management of asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 99(10):3607\u20133618","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"3543_CR12","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1210\/jc.2014-1413","volume":"99","author":"JP Bilezikian","year":"2014","unstructured":"Bilezikian JP, Brandi ML, Eastell R et al (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop. J Clin Endocrinol Metab 99(10):3561\u20133569","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"3543_CR13","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.suc.2009.06.011","volume":"89","author":"SC Pitt","year":"2009","unstructured":"Pitt SC, Sippel RS, Chen H (2009) Secondary and tertiary hyperparathyroidism, state of the art surgical management. Surg Clin North Am 89(5):1227\u20131239","journal-title":"Surg Clin North Am"},{"key":"3543_CR14","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1097\/BRS.0000000000001061","volume":"40","author":"AD Furlan","year":"2015","unstructured":"Furlan AD, Malmivaara A, Chou R et al (2015) 2015 Updated method guideline for systematic reviews in the cochrane back and neck group. Spine 40:1660\u20131673","journal-title":"Spine"},{"key":"3543_CR15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603\u2013605","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"3543_CR16","first-page":"497","volume":"34","author":"CQ Pan","year":"2021","unstructured":"Pan CQ, Zhou XC, Peng L et al (2021) Microwave ablation versus radiofrequency ablation for patients with chronic kidney disease complicated with SHPT. Chin J Clin Res 34(4):497\u2013500","journal-title":"Chin J Clin Res"},{"issue":"1","key":"3543_CR17","first-page":"89","volume":"41","author":"RR Ru","year":"2019","unstructured":"Ru RR, Li MK, Chen WP et al (2019) Comparison of two thermal ablation methods using ultrasonic guidance in the treatment of secondary hyperparathyroidism. Zhejiang Med J 41(1):89\u201391","journal-title":"Zhejiang Med J"},{"issue":"21","key":"3543_CR18","first-page":"3466","volume":"32","author":"J Yuan","year":"2021","unstructured":"Yuan J (2021) Efficacy analysis of ultrasound-guided radiofrequency ablation in patients with secondary hyperparathyroidism. Mod Diagn Treat 32(21):3466\u20133468","journal-title":"Mod Diagn Treat"},{"issue":"1","key":"3543_CR19","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1080\/02656736.2021.1945689","volume":"38","author":"Y Wei","year":"2021","unstructured":"Wei Y, Peng CZ, Wang SR et al (2021) Microwave ablation versus radiofrequency ablation for primary hyperparathyroidism: a multicenter retrospective study. Int J Hyperthermia 38(1):1023\u20131030","journal-title":"Int J Hyperthermia"},{"issue":"11","key":"3543_CR20","doi-asserted-by":"publisher","first-page":"7743","DOI":"10.1007\/s00330-022-08851-y","volume":"32","author":"F Liu","year":"2022","unstructured":"Liu F, Liu Y, Peng C et al (2022) Ultrasound-guided microwave and radiofrequency ablation for primary hyperparathyroidism: a prospective, multicenter study. Eur Radiol 32(11):7743\u20137754","journal-title":"Eur Radiol"},{"key":"3543_CR21","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/hed.24657","volume":"39","author":"C Peng","year":"2017","unstructured":"Peng C, Zhang Z, Liu J et al (2017) Efficacy and safety of ultrasound-guided radiofrequency ablation of hyperplastic parathyroid gland for secondary hyperparathyroidism associated with chronic kidney disease. Head Neck 39:564\u2013571","journal-title":"Head Neck"},{"issue":"1","key":"3543_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169655","volume":"12","author":"LH Lee","year":"2017","unstructured":"Lee LH, Hwang JI, Cheng YC et al (2017) Comparable outcomes of ultrasound versus computed tomography in the guidance of radiofrequency ablation for hepatocellular carcinoma. PLoS ONE 12(1):e0169655","journal-title":"PLoS ONE"},{"issue":"1","key":"3543_CR23","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1080\/0886022X.2019.1666724","volume":"41","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Lu Y, Feng S, Zhan Z et al (2019) Evaluation of laboratory parameters and symptoms after parathyroidectomy in dialysis patients with secondary hyperparathyroidism. Ren Fail 41(1):921\u2013929","journal-title":"Ren Fail"},{"issue":"1\u20132","key":"3543_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000486172","volume":"59","author":"R Schneider","year":"2018","unstructured":"Schneider R, Steinmetz C, Karakas E et al (2018) Influence of parathyroidectomy on bone metabolism and bone pain in patients with secondary hyperparathyroidism. Eur Surg Res 59(1\u20132):35\u201347","journal-title":"Eur Surg Res"},{"issue":"4","key":"3543_CR25","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/MNH.0000000000000327","volume":"26","author":"N Jain","year":"2017","unstructured":"Jain N, Reilly RF (2017) Hungry bone syndrome. Curr Opin Nephrol Hypertens 26(4):250\u2013255","journal-title":"Curr Opin Nephrol Hypertens"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03543-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-023-03543-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03543-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T17:20:27Z","timestamp":1691428827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-023-03543-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,9]]},"references-count":25,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["3543"],"URL":"https:\/\/doi.org\/10.1007\/s11255-023-03543-y","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,9]]},"assertion":[{"value":"11 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}